NDC 24208-443
Lotemax
Loteprednol Etabonate
Lotemax is a Ophthalmic Ointment in the Human Prescription Drug category. It is labeled and distributed by Bausch & Lomb Incorporated. The primary component is Loteprednol Etabonate.
| Product ID | 24208-443_98caf522-53b7-41a0-b960-6bee4d37623c |
| NDC | 24208-443 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Lotemax |
| Generic Name | Loteprednol Etabonate |
| Dosage Form | Ointment |
| Route of Administration | OPHTHALMIC |
| Marketing Start Date | 2011-04-15 |
| Marketing Category | NDA / NDA |
| Application Number | NDA200738 |
| Labeler Name | Bausch & Lomb Incorporated |
| Substance Name | LOTEPREDNOL ETABONATE |
| Active Ingredient Strength | 5 mg/g |
| Pharm Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
Packaging
NDC 24208-443-01
1 TUBE in 1 CARTON (24208-443-01) > 1 g in 1 TUBE
| Marketing Start Date | 2011-04-15 |
| NDC Exclude Flag | N |
| Sample Package? | Y |
NDC SPL Data Element Entries
NDC 24208-443-01 [24208044301]
Lotemax OINTMENT
| Marketing Category | NDA |
| Application Number | NDA200738 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2011-04-15 |
NDC 24208-443-35 [24208044335]
Lotemax OINTMENT
| Marketing Category | NDA |
| Application Number | NDA200738 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | GM |
| Marketing Start Date | 2011-04-15 |
Drug Details
Active Ingredients
| Ingredient | Strength |
|---|---|
| LOTEPREDNOL ETABONATE | 5 mg/g |
OpenFDA Data
| SPL SET ID: | 902a3c6b-2625-44ec-a077-926e012b3176 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
Pharmacological Class
- Corticosteroid [EPC]
- Corticosteroid Hormone Receptor Agonists [MoA]
Medicade Reported Pricing
24208044335 LOTEMAX 0.5% EYE OINTMENT
Pricing Unit: GM | Drug Type:
NDC Crossover Matching brand name "Lotemax" or generic name "Loteprednol Etabonate"
| NDC | Brand Name | Generic Name |
|---|---|---|
| 24208-299 | LOTEMAX | loteprednol etabonate |
| 24208-443 | Lotemax | loteprednol etabonate |
| 24208-503 | LOTEMAX | loteprednol etabonate |
| 24208-353 | Alrex | loteprednol etabonate |
| 71571-333 | Eysuvis | loteprednol etabonate |
| 71571-121 | Inveltys | loteprednol etabonate |
| 24208-507 | Lotemax SM | loteprednol etabonate |
| 17478-830 | Loteprednol Etabonate | Loteprednol Etabonate |
| 24208-508 | Loteprednol Etabonate | loteprednol etabonate |
| 50383-265 | Loteprednol Etabonate | Loteprednol Etabonate |
| 62756-232 | Loteprednol Etabonate | Loteprednol Etabonate |
| 68682-299 | Loteprednol Etabonate | loteprednol etabonate |
Trademark Results [Lotemax]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 LOTEMAX 74610747 2182587 Live/Registered |
BAUSCH & LOMB INCORPORATED 1994-12-13 |
© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.